IP Verse

Methods Of Treating Pediatric Patients Using Dexmedetomidine - EP2766014B1

PatentPatent Analysis

EP2766014

HOSPIRA
Application Number
EP12840033A
Filing Date
Sep 27, 2012
Status
Revoked
Jan 22, 2021
Grant Date
Jul 18, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3046603B1
EP2648520B1

Bibliography

The patent EP2766014B1 was granted to Hospira on Jul 18, 2018 following the initial filing on Sep 27, 2012 under the application number EP12840033A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

FRESENIUS KABI DEUTSCHLANDApr 16, 2019 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents